昊海生科
(688366)
| 流通市值：55.91亿 | | | 总市值：65.93亿 |
| 流通股本：1.94亿 | | | 总股本：2.29亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,179,123,113.77 | 571,435,147.56 | 2,472,998,092.33 | 1,899,085,771.17 |
| 营业总成本 | 1,062,123,384.97 | 490,119,504.05 | 2,136,274,101.02 | 1,600,891,868.22 |
| 其他经营收益 | | | | |
| 营业利润 | 132,949,088.64 | 96,357,694.57 | 220,209,887.59 | 325,895,731.73 |
| 利润总额 | 132,583,629.18 | 96,259,791.09 | 239,245,079.32 | 345,503,494.88 |
| 净利润 | 110,520,855.76 | 71,659,542.45 | 208,321,385.24 | 294,471,389.03 |
| 每股收益 | | | | |
| 其他综合收益 | -78,134,098.8 | -57,093,649.9 | 30,446,529.13 | 54,683,384.92 |
| 综合收益总额 | 32,386,756.96 | 14,565,892.55 | 238,767,914.37 | 349,154,773.95 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,344,548,073.23 | 3,389,948,689.23 | 3,462,814,473.51 | 3,623,223,635.87 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,214,310,324.46 | 3,276,360,372.45 | 3,257,249,176.56 | 3,494,848,693.82 |
| 资产总计 | 6,558,858,397.69 | 6,666,309,061.68 | 6,720,063,650.07 | 7,118,072,329.69 |
| 流动负债: | | | | |
| 流动负债合计 | 957,903,669.95 | 908,500,894.17 | 914,671,864.93 | 961,114,264.37 |
| 非流动负债: | | | | |
| 非流动负债合计 | 142,906,403.16 | 157,357,342.46 | 200,888,930.63 | 272,550,266.5 |
| 负债合计 | 1,100,810,073.11 | 1,065,858,236.63 | 1,115,560,795.56 | 1,233,664,530.87 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,303,033,399.42 | 5,443,261,193.54 | 5,421,780,976.7 | 5,615,759,432.49 |
| 股东权益合计 | 5,458,048,324.58 | 5,600,450,825.05 | 5,604,502,854.51 | 5,884,407,798.82 |
| 负债和股东权益合计 | 6,558,858,397.69 | 6,666,309,061.68 | 6,720,063,650.07 | 7,118,072,329.69 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,306,276,252.49 | 650,428,032.37 | 2,840,834,959.64 | 2,113,862,818.01 |
| 经营活动现金流出小计 | 1,178,369,119.3 | 631,853,793.7 | 2,349,862,453.83 | 1,736,841,930.54 |
| 经营活动产生的现金流量净额 | 127,907,133.19 | 18,574,238.67 | 490,972,505.81 | 377,020,887.47 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 531,743,674.78 | 146,744,116.18 | 1,694,940,423.04 | 457,453,764.05 |
| 投资活动现金流出小计 | 1,030,680,812.48 | 676,421,450.29 | 1,494,392,589.4 | 844,603,260.5 |
| 投资活动产生的现金流量净额 | -498,937,137.7 | -529,677,334.11 | 200,547,833.64 | -387,149,496.45 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 313,393,806.78 | 91,900,000 | 236,493,806.78 | 230,093,806.78 |
| 筹资活动现金流出小计 | 429,268,552.29 | 97,952,291.83 | 817,152,590.84 | 572,175,073.21 |
| 筹资活动产生的现金流量净额 | -115,874,745.51 | -6,052,291.83 | -580,658,784.06 | -342,081,266.43 |
| 汇率变动对现金及现金等价物的影响 | -19,865,487.06 | -12,971,577.51 | 4,630,692.03 | 5,236,300.8 |
| 现金及现金等价物净增加额 | -506,770,237.08 | -530,126,964.78 | 115,492,247.42 | -346,973,574.61 |
| 期末现金及现金等价物余额 | 721,627,754.6 | 698,271,026.9 | 1,228,397,991.68 | 765,932,169.65 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -506,770,237.08 | - | 115,492,247.42 | - |